Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Glioma: Glioblastoma (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00036972
What this trial is testing

Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01051557
What this trial is testing

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Testing effectiveness (Phase 2)Study completedNCT00671970
What this trial is testing

Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 57
Early research (Phase 1)Study completedNCT00064779
What this trial is testing

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 18
Testing effectiveness (Phase 2)Study completedNCT00704288
What this trial is testing

Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Exelixis 222
Early research (Phase 1)Study completedNCT02238496
What this trial is testing

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

Who this might be right for
Brain Tumor, RecurrentGlioblastomaAnaplastic Astrocytoma+2 more
Andrew B Lassman, MD 10
Not applicableLooking for participantsNCT05839379
What this trial is testing

Targeted Pediatric High-Grade Glioma Therapy

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+6 more
Nationwide Children's Hospital 350
Testing effectiveness (Phase 2)Study completedNCT00004113
What this trial is testing

Temozolomide in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02885324
What this trial is testing

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaMalignant Brain Tumor+1 more
Indiana University 4
Testing effectiveness (Phase 2)Study completedNCT01464177
What this trial is testing

Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Andre Tsin Chih Chen 40
Not applicableNot Yet RecruitingNCT05641220
What this trial is testing

Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.

Who this might be right for
Glioblastoma
Erasmus Medical Center 325
Testing effectiveness (Phase 2)Study completedNCT00042991
What this trial is testing

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

Who this might be right for
Untreated Childhood Anaplastic AstrocytomaUntreated Childhood Anaplastic OligodendrogliomaUntreated Childhood Brain Stem Glioma+5 more
National Cancer Institute (NCI) 69
Early research (Phase 1)Active Not RecruitingNCT03152318
What this trial is testing

The Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+11 more
Dana-Farber Cancer Institute 62
Testing effectiveness (Phase 2)WithdrawnNCT00243490
What this trial is testing

Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors

Who this might be right for
Malignant Intracranial TumorsGlioblastoma MultiformeAnaplastic Astrocytomas+2 more
National Taiwan University Hospital 5
Early research (Phase 1)Study completedNCT00045565
What this trial is testing

Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03919071
What this trial is testing

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic Astrocytoma, Not Otherwise SpecifiedAnaplastic Ganglioglioma+5 more
National Cancer Institute (NCI) 58
Early research (Phase 1)Study completedNCT00610571
What this trial is testing

Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma
Katy Peters 62
Early research (Phase 1)Looking for participantsNCT07544992
What this trial is testing

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma, IDH-Wildtype
City of Hope Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT01663012
What this trial is testing

Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma

Who this might be right for
Anaplastic AstrocytomasAnaplastic OligodendrogliomasGlioblastomas (GBM)
Lawrence Recht 20
Next Page